MetaADEDB 2.0 @ LMMD
Sandostatin LAR Depot
(QWFYIFWTVZFPRY-AARKYNAGSA-N)
Structure
SMILES
CC(=O)O.CC(=O)O.NCCCCC1NC(=O)C(NC(=O)C(Cc2ccccc2)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(O)C)C(=O)N[C@@H]([C@H](O)C)CO)NC(=O)C(Cc1ccccc1)N)Cc1c[nH]c2c1cccc2
Molecular Formula:
C53H74N10O14S2
Molecular Weight:
1139.340
Log P:
3.2028
Hydrogen Bond Acceptor:
25
Hydrogen Bond Donor:
15
TPSA:
457.42
CAS Number(s):
N/A
Synonym(s)
1.
Sandostatin LAR Depot
External Link(s)
PubChem Compound54373
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 2US FAERS
2MalaiseFAERS: 2US FAERS
3Malignant neoplasm progressionFAERS: 2US FAERS
4VomitingFAERS: 2US FAERS
5Abdominal PainFAERS: 1US FAERS
6AstheniaFAERS: 1US FAERS
7Congenital cystic kidney diseaseFAERS: 1US FAERS
8ConstipationFAERS: 1US FAERS
9Disease ProgressionFAERS: 1US FAERS
10DizzinessFAERS: 1US FAERS
11Drug administration errorFAERS: 1US FAERS
12DysuriaFAERS: 1US FAERS
13Early satietyFAERS: 1US FAERS
14Feeling ColdFAERS: 1US FAERS
15FlushingFAERS: 1US FAERS
16Full blood count increasedFAERS: 1US FAERS
17General physical health deteriorationFAERS: 1US FAERS
18HeadacheFAERS: 1US FAERS
19HepatomegalyFAERS: 1US FAERS
20IleusFAERS: 1US FAERS
21Increased tendency to bruiseFAERS: 1US FAERS
22Localised intraabdominal fluid collectionFAERS: 1US FAERS
23LymphadenopathyFAERS: 1US FAERS
24Mental impairmentFAERS: 1US FAERS
25NauseaFAERS: 1US FAERS
26NoduleFAERS: 1US FAERS
27PainFAERS: 1US FAERS
28Pancreatic carcinomaFAERS: 1US FAERS
29Pericardial effusionFAERS: 1US FAERS
30PruritusFAERS: 1US FAERS
31Renal painFAERS: 1US FAERS
32Umbilical herniaFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120263

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.